International Journal of Clinical & Experimental Dermatology
International Journal of Clinical & Experimental Dermatology
International Journal of Clinical & Experimental Dermatology
Corresponding author
*
Abstract
Background: Necrolytic acral erythema (NAE) is a rare dermatosis which has been regarded as an early cutaneous
marker of hepatitis C virus infection. The clinical manifestasion of NAE is similar to necrolytic migratory erythema,
psoriasis and tinea corporis. The difference is that the patients with NAE also suffer from hepatitis C virus infection.
Case: A 59 year old woman came and complained about itchy erythematous-violaceous plaques since a year ago. The
patient has a history of hepatitis C infection since 2 years ago. On the superior and inferior extremities region, there
were erythematous-violaceous plaques witch is partially hyperpigmentation with well-demarcated border, multiple
discretes with thin scales and lichenification. Histopathological examination of the lesion obtained psoriasiform,
hyperkeratosis, neutophylic microabscess, epidermal necrosis, spongiosis and infiltration of inflammatory cells in
the epidermis.
Discussion: Necrolytic acral erythema has been reported exclusively in patients with hepatitis C and is thought to
be pathognomonic of this infection. Acute lesions often show erythema with vesicles and flaccid bullae. Chronic
lesions appear as erythematous to violaceous plaques with thick scales, erosions and crust. Acral sites are
predominantly involved. The histopathological examination shows psoriasiform hyperplasia epidermal, neutrophylic
microabscesses, dilatation of small vessels, parakeratosis and infiltration of inflammatory cells. In this case, the
physical and histopathological examination support the diagnosis of NAE.
Keywords: Hepatitis c, necrolytic acral erythema. In most cases, the mechanisms which triggers or worsens the skin
manifestations of HCV infection are still unknown and further
Introduction examination is needed [4]. Some of the dermatological features of
Hepatitis C virus (HCV) is a type of ribonucleic acid (RNA) virus HCV infection are: mixed cryglobulinemia, polyarteritis nodusa
with 6 major genotypes. This virus is responsible for acute and (PAN), necrolytic acral erythema (NAE), red finger syndrome,
chronic hepatitis, cirrhosis, and liver cancer [1]. The World Health porfiria cutanea tarda, puritus, and planus lichen [5]. Beside that,
Organization (WHO) estimated that around 170 million people in other dermatological features caused by HCV are: urticaria,
the world is infected with hepatitis C. This virus is considered a vasculitis urticaria, and multiform erythema [6].
global health problem, because of its prevalence of intra and extra
hepatic features. About 85% of the cases developed into chronic Necrolytic acral erythema (NAE) was first described by el Darouti
hepatitis. Chronic hepatitis C viral infection often shows varied et al in 1996 [7-12]. Necrolytic acral erythema (NAE) is a rare
difference of clinical spectrum, from asymptomatic with normal skin condition in hepatitis C patients and is thought to be related to
enzyme level to severe active chronic hepatitis. Therefore, early zinc deficiency, although the mechanism is unclear. This problem
diagnosis is mandatory [2]. A recent study showed that around 70- has been reported in around the world, such as Pakistan, India, and
74% cases manifest to extra hepatic features [3]. the United States with the majority of cases was found in Egypt.
It may be related to the higher prevalence of hepatitis C in Egypt
Extra hepatic manifestations of HCV infection include abnormalities (more than 20%) than other places in the world (3%). One cohort
of the blood, skin, and kidney, autoimmune manifestation, and study showed that the prevalence of NAE in hepatitis C patients is
abnormalities of the nervous system, endocrine, cardiovascular and around 1.7% [13].
respiratory [1]. Skin is the main target of extra hepatic feature of
HCV infection. There are some factors causing the HCV-related The etiology of NAE is multi factorial and liver dysfunction is
skin abnormalities, such as viral, genetic, and environmental factors. known to be related to the development of the disease. Very little
Case
A 59 years old woman came to the Dermatovenereology Outpatient
Clinic of Moewardi General Hospital Surakarta Indonesia and
complained about painless, itchy, erythematous-violaceous plaques
on her hands and legs since 1 year ago. At first, she complained about
vesicles filled with fluid and erythematous plaques, but then the
vesicles ruptured. Then the plaques became violaceous accompanied
with thin scales. The symptoms occurred after the patient was infected
with hepatitis C virus 2 years ago. The patient also suffered from
diabetes since 5 months ago and she already got the medications for
her diabetes from Internal Medicine Clinic of Moewardi General
Hospital. The physical examination revealed normal range, on the Figure 2: (A) Histopathology examination using HE staining with 10x
superior and inferior extremities we found erythematous-violaceous magnification shows psoriasiform image, neutrophilic microabscess,
plaques with hyperpigmentation and well-demarcated border, discrete, epidermal necrosis, and inflammatory cells infiltration. (B) With 40x
and lichenified with thin scales (Figure. 1). magnification we found hyperkeratosis and spongiosis.
Discussion
Hepatitis C is an inflammation of the liver caused by HCV infection.
The disease transmission is from direct contact with contaminated
blood. This inflammation occurs in most of the infected people,
but it depends on the intensity and duration. Unlike other hepatitis
viruses, HCV does not induce adequate immune response so the
acute manifestations are often subtle and most of the infected people
become carrier of chronic hepatitis with long term consequences. The
disease is also reported transmitted via secrete (breast milk, saliva,
urine, and sperm). This virus can survive in the outside for 16 hours to
4 days. There are several genotypes (variant) of this virus. We order to
establish the diagnosis of hepatitis C we need to identify the anti-HCV
antibody using ELISA [2].